← All stocks

Anixa Biosciences Inc

ANIX Net buying
CIK 0000715446 #4223 in the set updated 17 Sep 2026
Bought (120 mo)
$3.54M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$158.13K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$158.13K
2 of 2 sales
Net
+$3.38M
+$3.38M against sales at will

By person

11 insiders · 122 transactions
2.2×

Dr. Amit Kumar holds only 2.2 times base salary in stock. $1.82M of shares against $815.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Dr. Amit Kumar last reported holding, valued at $2.73, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Titterton Lewis H jr
Director
$1.67M (43)
+$1.67M
996,967
2.93%
$2.72M
+27.5%
KUMAR AMIT
Chief Executive Officer
$1.08M (37)
$42.13K (1)
+$1.04M
665,000
1.95%
$1.82M
+541.1%
Baskies Arnold M
Director
$484.17K (13)
+$484.17K
135,572
0.3985%
$370.11K
+13,457%
Gottschalk Emily
Director
$200.49K (3)
+$200.49K
45,665
0.1342%
$124.67K
WILLIAMS RICHARD H
Director
$116.00K (1)
−$116.00K
125,000
0.3674%
$341.25K
+25.0%
Catelani Michael
President, COO & CFO
$85.98K (6)
+$85.98K
44,500
0.1308%
$121.49K
+2,224,900%
BERMAN ROBERT ANDREW
President & CEO
$8.80K (2)
+$8.80K
61,553
0.1809%
$168.04K
+35.1%
Cavalier David
Director
$8.42K (1)
+$8.42K
2,000
0.0059%
$5.46K
MONAHAN JOHN J
Director
$3.80K (1)
+$3.80K
50,900
0.1496%
$138.96K
JOHNSON BRUCE F
Director
604,817
1.78%
$1.65M
+9.0%
HERMS HENRY P
VP, Finance & CFO
23,321
0.0685%
$63.67K
+5.4%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 196
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 2,646,583
Sales filed before the plan box existed 1
History held since 24 Oct 2016